Medical News

RSS

MedImmune starts phase 2 trial of antibody targeting IL-5 receptor

MedImmune has announced that it has initiated a Phase 2 clinical trial in patients with chronic asthma to determine the safety of subcutaneous dosing of a humanized monoclonal antibody (MAb) that targets the interleukin-5 receptor (IL-5R).

8 Dec 2008

Study finds it generally safe to withdraw anti-seizure medication in children with epilepsy

A new Mayo Clinic study found that it is generally safe to withdraw anti-seizure medications in children with epilepsy who have achieved seizure-freedom while on the medication.

8 Dec 2008

Brain's circuitry survives longer than previously thought in Alzheimer's

Researchers at the Babraham Institute near Cambridge, supported by the Alzheimer's Research Trust and the Biotechnology and Biological Sciences Research Council (BBSRC), have discovered that the brain's circuitry survives longer than previously thought in diseases of ageing such as Alzheimer's disease.

8 Dec 2008

Kiadis Pharma announces positive results for ATIR in mismatched bone marrow transplantation

Biopharmaceutical company Kiadis Pharma announces that it has successfully completed treatment of the last patient on its ATIR phase I/II clinical trial.

8 Dec 2008

ISTA Pharmaceuticals announces trial results for topical Xibrom 0.09%

ISTA Pharmaceuticals, Inc. has announced results from the Company's recently completed Phase III clinical program of Xibrom (0.09% bromfenac sodium ophthalmic solution) QD (once-daily).

8 Dec 2008

Incyte's selective Janus kinase inhibitor demonstrates rapid and durable clinical benefits in Myelofibrosis patients

Incyte Corporation will present updated results from an ongoing Phase II trial of INCB18424, its selective, orally available Janus kinase (JAK) inhibitor, in patients with myelofibrosis (MF) at the 50th American Society of Hematology (ASH) Annual Meeting.

8 Dec 2008

Fractional dose of scarce meningitis vaccine may be effective in outbreak control

One fifth of the standard dose of a commonly used meningitis vaccine may be as effective as using the full dose.

8 Dec 2008

FDA advisory committee recommends approval of LATISSE as a treatment for hypotrichosis of eyelashes

Allergan, Inc. has announced the U.S. Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) voted unanimously (9-0) to recommend that the FDA approve LATISSE (bimatoprost solution 0.03%) as a treatment for hypotrichosis (or reduced amount of hair) of the eyelashes.

8 Dec 2008

FDA advisory committee to dscuss PMA for Genzyme's Synvisc-One

Genzyme Corporation has announced that its Premarket Approval (PMA) application supplement for Synvisc-One (hylan G-F 20) will be discussed this Tuesday, December 9th, at a public meeting of the FDA's Orthopaedic and Rehabilitation Devices Advisory Committee in Gaithersburg, Maryland.

8 Dec 2008

FDA advisory committee recommends approval for Bausch & Lomb's besifloxacin ophthalmic suspension

The U.S. Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee today voted unanimously to recommend approval of Bausch & Lomb's besifloxacin ophthalmic suspension, 0.6%, for the treatment of bacterial conjunctivitis.

8 Dec 2008

Dismissed leukemia drug flavopiridol helps chronic lymphocytic leukemia patients

A drug once dismissed as ineffective in patients with chronic lymphocytic leukemia (CLL) has shown promising results in two phase I and II clinical trials, according to researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.

8 Dec 2008

Biomarkers in blood could aid diagnosis of two severe and debilitating forms of malaria

Canadian researchers have identified protein biomarkers that shed new light on the development of two severe and debilitating forms of malaria.

8 Dec 2008

BD Diagnostics receives FDA approval for imaging system that enhances detection of cervical cancer

BD Diagnostics, a segment of BD (Becton, Dickinson and Company) has announced that it received U.S. Food and Drug Administration (FDA) Premarket Approval (PMA) for the BD FocalPoint(TM) GS Imaging System.

From BD (Becton, Dickinson and Company) 8 Dec 2008

Azur Pharma to acquire U.S. rights to Elestrin

Azur Pharma Limited has announced that it has entered into a definitive agreement with BioSante Pharmaceuticals, Inc to acquire U.S. rights to Elestrin.

8 Dec 2008

Allos Therapeutics announces results from phase 2 trial of Pralatrexate in peripheral T-cell lymphoma

Allos Therapeutics, Inc. has announced preliminary top line results from PROPEL, the Company's pivotal Phase 2 trial of pralatrexate (PDX) in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL), at the 50th Annual Meeting of the American Society of Hematology (abstract 261).

8 Dec 2008

Anti-seizure drug Epilim shows promise for Alzheimer's

A drug commonly used to treat epilepsy could help clear the plaques in the brain associated with Alzheimer's disease, according to researchers at the University of Leeds. The plaques are known to lead to the progressive death of nerve cells in the brain linked to many forms of dementia.

8 Dec 2008

Hormone Oxytocin calms arguing couples

A dose of the hormone Oxytocin reduces the stress hormone Cortisol in arguing couples. In addition, Oxytocin strengthens positive behaviour, as researchers at the University of Zurich have discovered. The study by the psychologist Beate Ditzen has appeared in the specialist magazine "Biological Psychiatry".

8 Dec 2008

Calls for all pregnant women to be screened for Down syndrome

Experts say Australia needs a national screening policy for Down syndrome as research shows it could halve the number of babies born with the genetic condition.

8 Dec 2008

Marathon champion McCann loses second battle with cancer

The Commonwealth Games gold medallist Kerryn McCann has died from cancer at the age of 41.

8 Dec 2008

Australian men need the 'right doctors'

Researchers from the University of Adelaide say regardless of the preconceived stereotype surrounding men and their health, Australian men are interested in talking about their health with the 'right people' and most men do not like the way that many doctors work.

8 Dec 2008

Medical News

MedImmune starts phase 2 trial of antibody targeting IL-5 receptor

Study finds it generally safe to withdraw anti-seizure medication in children with epilepsy

Brain's circuitry survives longer than previously thought in Alzheimer's

Kiadis Pharma announces positive results for ATIR in mismatched bone marrow transplantation

ISTA Pharmaceuticals announces trial results for topical Xibrom 0.09%

Incyte's selective Janus kinase inhibitor demonstrates rapid and durable clinical benefits in Myelofibrosis patients

Fractional dose of scarce meningitis vaccine may be effective in outbreak control

FDA advisory committee recommends approval of LATISSE as a treatment for hypotrichosis of eyelashes

FDA advisory committee to dscuss PMA for Genzyme's Synvisc-One

FDA advisory committee recommends approval for Bausch & Lomb's besifloxacin ophthalmic suspension

Dismissed leukemia drug flavopiridol helps chronic lymphocytic leukemia patients

Biomarkers in blood could aid diagnosis of two severe and debilitating forms of malaria

BD Diagnostics receives FDA approval for imaging system that enhances detection of cervical cancer

Azur Pharma to acquire U.S. rights to Elestrin

Allos Therapeutics announces results from phase 2 trial of Pralatrexate in peripheral T-cell lymphoma

Anti-seizure drug Epilim shows promise for Alzheimer's

Hormone Oxytocin calms arguing couples

Calls for all pregnant women to be screened for Down syndrome

Marathon champion McCann loses second battle with cancer

Australian men need the 'right doctors'

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News